- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.05. | Morning Market Movers: Robo.ai, Antelope Enterprise Holdings, WORK Medical Technology Group, POET Technologies See Big Swings | 782 | AFX News | SAN FRANCISCO (dpa-AFX) - At 8:20 a.m. ET on Thursday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the... ► Artikel lesen | |
| WORK MEDICAL TECHNOLOGY GROUP Aktie jetzt für 0€ handeln | |||||
| 13.05. | WORK Medical Technology Group Is Trending Overnight - Here's Why WOK Stock Surged Over 69% In After-Hours Session | 19 | Benzinga.com | ||
| 11.05. | WORK Medical Technology Group LTD: WORK Medical Collaborates with Novabioplus to Unlock Biological Data Value with AI, Advancing the "BioToken" Assetization Model | 18 | GlobeNewswire (USA) | ||
| 01.05. | WORK Medical Technology Group LTD: WORK Medical Deepens Web3.0 Strategic Layout: Co-authors Asset Tokenization Whitepaper | 1 | GlobeNewswire (USA) | ||
| 15.04. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 27.02. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 10.02. | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 30.01. | WORK Medical Technology Group LTD - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 30.12.25 | Work Medical Technology Group schließt Aktienzusammenlegung im Verhältnis 100:1 ab | 5 | Investing.com Deutsch | ||
| 30.12.25 | WORK Medical Technology Group LTD - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 29.12.25 | WORK Medical Shares Jump 9% On Exclusive AI Blood Analysis Deal In China | 1 | RTTNews | ||
| 29.12.25 | WORK Medical Signs East China Distribution Deal For AI Blood Analyzer, Stock Up | 1 | RTTNews | ||
| 29.12.25 | Produktionszulassung für KI-Blutanalysegerät beflügelt Aktie von WORK Medical | 2 | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical subsidiary signs exclusive distribution deal for blood analyzer | 1 | Investing.com | ||
| 29.12.25 | WORK Medical schließt exklusiven Vertriebsvertrag für KI-Blutanalysegerät in Ostchina | - | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical Technology Group LTD: WORK Medical Grants East China Exclusive Distribution Rights for AI-Automated Blood Cell Morphology Analyzer, Sets RMB10 Million Sales Target for 2026 | 508 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical", the "Company" or "we"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 29.12.25 | HANGZHOU - WORK Medical subsidiary receives AI blood analyzer approval | 1 | Investing.com | ||
| 29.12.25 | WORK Medical erhält Zulassung für KI-gestütztes Blutanalysegerät | 1 | Investing.com Deutsch | ||
| 29.12.25 | WORK Medical Technology Group LTD Subsidiary Obtains Manufacturing Approval for Its AI-Automated Blood Cell Morphology Analyzer | 300 | GlobeNewswire (Europe) | Hangzhou, China, Dec. 29, 2025 (GLOBE NEWSWIRE) -- WORK Medical Technology Group LTD (Nasdaq: WOK) ("WORK Medical" or the "Company"), a supplier of medical devices in China, through its subsidiary... ► Artikel lesen | |
| 24.12.25 | WORK Medical führt Aktienzusammenlegung im Verhältnis 1:100 durch | 13 | Investing.com Deutsch |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,658 | -0,14 % | Teladoc Health, Inc. - 8-K, Current Report | ||
| HIMS & HERS HEALTH | 20,220 | -1,08 % | Countdown: 24. Mai, Las Vegas: Analysten sehen bei dieser Nasdaq-Aktie über 172% Kurschance - was steckt dahinter? | ||
| PLUS THERAPEUTICS | 5,840 | +7,35 % | Plus Therapeutics partners with Ephemeral on AI platform | ||
| HEALWELL AI | 0,550 | +0,18 % | HEALWELL verzeichnet im 1. Quartal 2026 eine Umsatzsteigerung von 316 % und verbessert die Kundenbindung | - HEALWELL erzielte im ersten Quartal 2026 einen Quartalsumsatz aus fortlaufender Betriebstätigkeit in Höhe von 33,2 Millionen $, was einem Anstieg um 316 % gegenüber dem im
ersten Quartal... ► Artikel lesen | |
| ORGANON | 11,540 | -0,26 % | Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia | SEOUL, South Korea, May 21, 2026 (GLOBE NEWSWIRE) -- Hanmi Pharmaceutical announced that it has signed a supply agreement with global healthcare company Organon to export three combination medicines... ► Artikel lesen | |
| CO-DIAGNOSTICS | 5,075 | +0,10 % | Co-Diagnostics, Inc. - 8-K, Current Report | ||
| VERU | 2,350 | 0,00 % | Veru Inc.: Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress | --Phase 2b PLATEAU clinical study evaluating enobosarm + semaglutide is actively enrolling and on track for interim analysis first quarter calendar year 2027- --Company to host conference call and... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,100 | +1,31 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| SENSEONICS | 5,500 | +0,92 % | Senseonics Holdings, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| ELEKTA | 5,575 | +0,36 % | Dividendenbekanntmachungen (05.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AMERICAN ASSETS TRUST INC US0240131047 0,34 USD 0,2922 EUR ARMSTRONG WORLD INDUSTRIES INC US04247X1028 0,339 USD 0,2914 EUR ASSOCIATED... ► Artikel lesen | |
| IMUNON | 1,660 | +1,84 % | Imunon verfehlt Gewinnprognose für Q1 2026 deutlich - Aktie gibt nach | ||
| PERSPECTIVE THERAPEUTICS | 3,300 | -3,40 % | Perspective Therapeutics, Inc.: Perspective Therapeutics Announces First Patients Dosed in New Cohorts of Two Ongoing Phase 1/2a Studies | SEATTLE, May 18, 2026 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. ("Perspective," the "Company," "we," "us," and "our") (NYSE AMERICAN: CATX), a radiopharmaceutical development company pioneering... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 29,000 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| AXOGEN | 34,940 | 0,00 % | Axogen, Inc.: Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | ALACHUA, Fla. and TAMPA, Fla., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral... ► Artikel lesen | |
| NIAGEN BIOSCIENCE | 3,140 | 0,00 % | Niagen Bioscience, Inc.: Niagen Bioscience is the Premiere Sponsor of the Inaugural "NAD for Health: Opportunities & Challenges" Conference Hosted by the University of Copenhagen | Taking place March 23-25, 2026, this three-day scientific forum will convene the world's foremost NAD experts in Copenhagen to advance evidence-based dialogue and accelerate clinical translation... ► Artikel lesen |
Das Unternehmen WORK MEDICAL TECHNOLOGY GROUP LTD kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +0,27 % bei einem Aktienkurs von 0,112 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WORK MEDICAL TECHNOLOGY GROUP LTD finden Sie auf Wallstreet Online.